Clinical Trial Feasibility Platform

Find the right sites. Faster.

Upload your protocol and let our AI do the rest to identify best trial sites, qualified investigators, and their complete research payment history—in minutes, not months.

Trusted by clinical operations teams at

Pharma Co.BioTech Inc.MedResearchClinOps Global
2M+
US Healthcare Providers
400K+
Global Clinical Trials
$12B+
Payment Records

From protocol to recommendations in four steps

Our AI-powered platform streamlines the entire Site and Investigator selection process, giving you actionable insights backed by real data.

01

Upload Protocol

Upload your clinical trial protocol. Our AI extracts eligibility criteria, diagnosis codes, and procedures automatically.

02

Discover Sites

Our AI analyzes Global Clinical Trials to find institutions with proven experience running similar trials.

03

Match Investigators

Identify qualified Principal Investigators based on specialty taxonomy and past trial participation.

04

Analyze Payments

Review research payment history from $12B Payments for comprehensive report after due diligence.

Sample Report

See what you'll get

Here's a real analysis from an Idiopathic Pulmonary Fibrosis trial. Upload your protocol and get similar insights in minutes.

Live Preview

IPF Protocol-FGCL

Phase IIcompleted

Idiopathic Pulmonary Fibrosis

1000

Sites Found

188

Investigators

$1.6M

Avg Payments

48

Week Duration

Protocol Summary

Condition

Idiopathic Pulmonary Fibrosis

Specialty

Pulmonology

Patient Criteria

Age Range

4080 years

Gender

any

Study Logistics

Duration

48 weeks

Visit Frequency

every 3 weeks

Treatment Type

IV infusion

Medical Codes

ICD-10 Codes

J84.112

MeSH Terms

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Taxonomy Codes

207RP1001X

Required Procedures

Keywords

FG-3019pamrevlumabIPFidiopathic pulmonary fibrosisCTGFconnective tissue growth factoranti-fibroticmonoclonal antibodyUIPusual interstitial pneumonia
Eligibility Criteria
1

Diagnosis of IPF per 2011 international guidelines with UIP pattern on HRCT or Possible UIP on HRCT plus surgical lung biopsy showing UIP pattern within 4 years

2

History of IPF ≤5 years duration from first diagnosis

3

HRCT showing ≥10% to <50% parenchymal fibrosis (reticulation) and <25% honeycombing

4

FVC ≥55% of predicted value at screening

5

Failed or intolerant of approved IPF treatments (nintedanib/pirfenidone) or treatment-naive patients who decline approved therapies

#1

Medical University of South Carolina

Charleston, South Carolina
16

trials

#2

Vanderbilt University Medical Center

Nashville, Tennessee
14

trials

#3

Massachusetts General Hospital

Boston, Massachusetts
14

trials

#4

University of Alabama at Birmingham

Birmingham, Alabama
14

trials

#5

University of Chicago

Chicago, Illinois
14

trials

#6

University of Kansas Medical Center

Kansas City, Kansas
13

trials

#7

University of Michigan

Ann Arbor, Michigan
13

trials

#8

National Jewish Health

Denver, Colorado
12

trials

#9

Duke University Medical Center

Durham, North Carolina
12

trials

#10

Southeastern Research Center

Winston-Salem, North Carolina
12

trials

+990 more sites in full report

Ready to analyze your own protocol?

Upload your clinical trial protocol and get a comprehensive feasibility report with recommended sites, qualified investigators, and payment history.

Features

Built for clinical operations teams

Every feature designed to reduce time-to-first-patient and improve site selection accuracy.

AI-Powered Extraction

Automatically parse complex protocol documents to extract structured eligibility criteria, ICD-10 codes, and required procedures.

Real-Time Data

Access up-to-date information from federal databases and other public sources of data.

Smart Matching

Our algorithms rank sites and investigators based on experience, specialty match, enrollment history and other criteria.

Compliance Ready

Full transparency into investigator payment history helps ensure regulatory compliance and conflict disclosure.

Pricing

Simple, transparent pricing

Start free, upgrade when you need more. No hidden fees.

Free Trial

Try it out with no commitment

$0
  • 2 protocol analyses
  • Full site & investigator reports
  • Payment history analysis
  • No credit card required

Pay Per Use

Buy credits and use them anytime

$499per protocol
  • Buy 1 or more credits at once
  • Full site & investigator reports
  • Payment history analysis
  • Credits never expire

Enterprise

For teams running multiple trials

$1,999/mo3-month minimum
  • 10 protocols per month
  • Full site & investigator reports
  • Payment history analysis
  • Auto-renewal billing
Testimonials

What our users say

Well developed and easy to use platform to accelerate Site Selection and Investigator identification. It reduces time by 15 to 20 days of effort.
NR
Nipun R
Director, Clinical Operations
TrialGuide helped us identify 40% more qualified investigators for our Phsase III oncology trial, cutting our site selection time from 4 months to 2 weeks.
SR
Sarah R.
VP Clinical Operations, Top 10 Global Pharma

Ready to accelerate your trial planning?

Join the Clinical Operations teams using TrialGuide to find better Sites and Investigators, faster. Start your free trial today—no credit card required.